v3.22.4

Accrued Expenses | 12 Months Ended
--- | ---
Dec. 31, 2022
Accrued Liabilities, Current [Abstract] |
Accrued Expenses | Accrued Expenses Accrued expenses consist of the following:
| December 31, 2022 |  | December 31, 2021
Compensation expenses | $ | 7,002,000 |  |  | $ | 4,529,000 |
Taxes payable | 825,000 |  |  | 677,000 |
Insurance | 613,000 |  |  | 1,011,000 |
Professional fees and royalties | 210,000 |  |  | 288,000 |
Warranty liabilities | 489,000 |  |  | 175,000 |
Accrued clinical study fees | 250,000 |  |  | 1,000 |
Customer deposits | 17,000 |  |  | 826,000 |
Other | 1,146,000 |  |  | 1,114,000 |
Total | $ | 10,552,000 |  |  | $ | 8,621,000 |

X
- Definition The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a),20,24) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_AccruedLiabilitiesCurrentAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration